News
Mushrooms sold across two states have been recalled over fears they could be harboring listeria, a bug that "can cause ...
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
The FDA on Tuesday rejected a skin therapy from Replimune Group, suggesting a hardened stance on drug approvals under new agency officials ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...
By Sriparna Roy and Sneha S K (Reuters) -The U.S. Food and Drug Administration said on Monday it has appointed former biotech ...
Explore more
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results